Physician
Radiation Oncology
Dr. Adam S. Garden, MD
|
|
Give Review
Adam S. Garden practices Radiation Oncology. He went to State University of New York Downstate Medical Center College of Medicine. Dr. Adam S. Garden is also a published physician. He has 100 publication published. The most recent publication is: Outcomes for hypopharyngeal carcinoma treated with organ-preservation therapy. Doctor Adam S. Garden, MD accepts Medicare payments and is listed with Medicare.gov.
Publications
- The Influence of Diabetes Mellitus and Metformin on Distant Metastases in Oropharyngeal Cancer: A Multicenter Study.
- Proposed Staging System for Patients With HPV-Related Oropharyngeal Cancer Based on Nasopharyngeal Cancer N Categories.
- Outcomes for hypopharyngeal carcinoma treated with organ-preservation therapy.
- Association of Body Composition With Survival and Locoregional Control of Radiotherapy-Treated Head and Neck Squamous Cell Carcinoma.
- Magnetic resonance imaging of swallowing-related structures in nasopharyngeal carcinoma patients receiving IMRT: Longitudinal dose-response characterization of quantit...
- Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma.
- Definitive proton radiation therapy and concurrent cisplatin for unresectable head and neck adenoid cystic carcinoma: A series of 9 cases and a critical review of the ...
- Prognostic value of p16 expression in Epstein-Barr virus-positive nasopharyngeal carcinomas.
- Metabolic Tumor Volume as a Prognostic Imaging-Based Biomarker for Head-and-Neck Cancer: Pilot Results From Radiation Therapy Oncology Group Protocol 0522.
- Orbital carcinomas treated with adjuvant intensity-modulated radiation therapy.
- Merkel cell carcinoma of the head and neck: Favorable outcomes with radiotherapy.
- Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: A 3-decade survey.
- Quality Assurance Assessment of Diagnostic and Radiation Therapy-Simulation CT Image Registration for Head and Neck Radiation Therapy: Anatomic Region of Interest-base...
- A choice of radionuclide: Comparative outcomes and toxicity of ruthenium-106 and iodine-125 in the definitive treatment of uveal melanoma.
- Characteristics and kinetics of cervical lymph node regression after radiation therapy for human papillomavirus-associated oropharyngeal carcinoma: Quantitative image ...
- Nomogram for Predicting Symptom Severity during Radiation Therapy for Head and Neck Cancer.
- A multi-institution pooled analysis of gastrostomy tube dependence in patients with oropharyngeal cancer treated with definitive intensity-modulated radiotherapy.
- The never-ending story: finding a role for neoadjuvant chemotherapy in the management of head and neck cancer.
- Prospective randomized double-blind study of atlas-based organ-at-risk autosegmentation-assisted radiation planning in head and neck cancer.
- Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522.
- Re: Patel et al.
- Management of the lymph node-positive neck in the patient with human papillomavirus-associated oropharyngeal cancer.
- Predicting oropharyngeal tumor volume throughout the course of radiation therapy from pretreatment computed tomography data using general linear models.
- CT Findings in Temporal Bone Osteoradionecrosis.
- Multifield Optimization Intensity Modulated Proton Therapy for Head and Neck Tumors: A Translation to Practice.
- Long-term functional and survival outcomes after induction chemotherapy and risk-based definitive therapy for locally advanced squamous cell carcinoma of the head and ...
- Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: A prospective analysis using the University of Texas MD Anders...
- Beam path toxicity in candidate organs-at-risk: Assessment of radiation emetogenesis for patients receiving head and neck intensity modulated radiotherapy.
- Final Results of Local-Regional Control and Late Toxicity of RTOG 9003: A Randomized Trial of Altered Fractionation Radiation for Locally Advanced Head and Neck Cancer.
- Improved survival using intensity-modulated radiation therapy in head and neck cancers: A SEER-Medicare analysis.
- Prognostic Factors Associated With Decreased Survival in Patients With Acinic Cell Carcinoma.
- Spot-scanning beam proton therapy vs intensity-modulated radiation therapy for ipsilateral head and neck malignancies: A treatment planning comparison.
- Anisotropic Margin Expansions in 6 Anatomic Directions for Oropharyngeal Image Guided Radiation Therapy.
- Prospective Assessment of an Atlas-Based Intervention Combined With Real-Time Software Feedback in Contouring Lymph Node Levels and Organs-at-Risk in the Head and Neck...
- The impact of radiographic retropharyngeal adenopathy in oropharyngeal cancer.
- Clinical characteristics of patients with multiple potentially HPV-related malignancies.
- Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st century.
- Adaptive radiotherapy for head and neck cancer-Dosimetric results from a prospective clinical trial.
- Head and neck carcinoma in the United States: first comprehensive report of the Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN).
- Evaluating the impact of patient, tumor, and treatment characteristics on the development of jaw complications in patients treated for oral cancers: A SEER-Medicare an...
- Patterns of Disease Recurrence Following Treatment of Oropharyngeal Cancer With Intensity Modulated Radiation Therapy.
- Variable planning margin approach to account for locoregional variations in setup uncertainties.
- Osteoradionecrosis and Radiation Dose to the Mandible in Patients With Oropharyngeal Cancer.
- An evolution in demographics, treatment, and outcomes of oropharyngeal cancer at a major cancer center: A staging system in need of repair.
- Comparing surgery and radiation in the treatment of oropharyngeal cancer.
- Prognostic factors in mucoepidermoid carcinoma of the salivary glands.
- Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial.
- Adaptive Radiotherapy for Head-and-Neck Cancer: Initial Clinical Outcomes from a Prospective Trial.
- Unilateral Radiotherapy for the Treatment of Tonsil Cancer.
- Radiation-associated head and neck sarcomas: Spectrum of imaging findings.
- Outcomes of malignant tumors of the lacrimal apparatus: The University of Texas MD Anderson Cancer Center experience.
- Impact of Gender, Partner Status, and Race on Locoregional Failure and Overall Survival in Head and Neck Cancer Patients in Three Radiation Therapy Oncology Group Trials.
- Longitudinal oncology registry of head and neck carcinoma (LORHAN): analysis of chemoradiation treatment approaches in the United States.
- DNA repair biomarker profiling of head and neck cancer: Ku80 expression predicts locoregional failure and death following radiotherapy.
- Outcomes of malignant tumors of the lacrimal apparatus: the University of Texas M. D. Anderson Cancer Center experience.
- Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy.
- Intensity-modulated radiotherapy for cervical node squamous cell carcinoma metastases from unknown head-and-neck primary site: M. D. Anderson Cancer Center outcomes an...
- To TORS or Not to TORS: but is that the question? Comment on "transoral robotic surgery for advanced oropharyngeal carcinoma".
- Prospective imaging assessment of mortality risk after head-and-neck radiotherapy.
- Anaplastic thyroid cancer: Clinical outcomes with conformal radiotherapy.
- Simple carotid-sparing intensity-modulated radiotherapy technique and preliminary experience for T1-2 glottic cancer.
- Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22).
- Outcomes of patients with tonsillar carcinoma treated with post-tonsillectomy radiation therapy.
- Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial.
- Clinical practice guidance for radiotherapy planning after induction chemotherapy in locoregionally advanced head-and-neck cancer.
- Mucositis-related morbidity and resource utilization in head and neck cancer patients receiving radiation therapy with or without chemotherapy.
- Complications of radiotherapy in laryngopharyngeal cancer: effects of a prospective smoking cessation program.
- Early postoperative paclitaxel followed by concurrent paclitaxel and cisplatin with radiation therapy for patients with resected high-risk head and neck squamous cell ...
- Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225.
- Hypothyroidism in older patients with head and neck cancer after treatment with radiation: a population-based study.
- Postoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with conformal treatment.
- Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer.
- Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancer.
- IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.
- Controversies in surgical management of the node-positive neck after chemoradiation.
- The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis.
- Beam path toxicities to non-target structures during intensity-modulated radiation therapy for head and neck cancer.
- Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased fre...
- Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy.
- Postoperative adjuvant external-beam radiation therapy for cancers of the eyelid and conjunctiva.
- Performance evaluation of automatic anatomy segmentation algorithm on repeat or four-dimensional computed tomography images using deformable image registration method.
- Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase II trial of the radiation therapy oncology gr...
- Salivary flow rates measured during radiation therapy in head and neck cancer patients: a pilot study assessing salivary sediment formation.
- Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis.
- Comparison of 2D radiographic images and 3D cone beam computed tomography for positioning head-and-neck radiotherapy patients.
- Postoperative radiotherapy for advanced medullary thyroid cancer--local disease control in the modern era.
- Outcomes after radiotherapy for basaloid squamous cell carcinoma of the head and neck: a case-control study.
- Long-term radiotherapy outcomes for nasal cavity and septal cancers.
- Concurrent epithelioid malignant peripheral nerve sheath tumor and papillary thyroid carcinoma in the treated field of Hodgkin's disease.
- Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysis.
- Psychosocial and economic impact of cancer.
- Outcomes after radiotherapy for squamous cell carcinoma of the eyelid.
- Open-label, long-term safety study of cevimeline in the treatment of postirradiation xerostomia.
- Parotid gland dose in intensity-modulated radiotherapy for head and neck cancer: is what you plan what you get?
- Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module.
- Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies.
- Postoperative radiotherapy for maxillary sinus cancer: long-term outcomes and toxicities of treatment.
- The role of interstitial brachytherapy with salvage surgery for the management of recurrent head and neck cancers.
- Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire.
Schools
SUNY Downstate Medical Center College Of Medicine
Staten Island Hospital
University Tex MD Anderson Hospital
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Education
-
University of Texas MD Anderson Cancer Center -
Staten Island University Hospital -
State University of New York Downstate Medical Center College of Medicine
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1871687475 | |
| NPPES Provider LastName | GARDEN | |
| NPPES Provider FirstName | ADAM | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 54.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 27.0 | |
| Percent Opioid Claims | 50.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1871687475 |
| Last Name Of The Provider | GARDEN |
| First Name Of The Provider | ADAM |
| View All |
Similar Doctors
|
|
Dr. Nalinakshi S. Rangala, MD |
|
|
Dr. Deborah A. Kuban, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven J. Frank, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Quynh-Nhu Nguyen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erik P. Sulman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alfredo E. Echeverria, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hubert Pan, MD |
|
|
Dr. Sean R. Quinlan-Davidson, MD |
|
|
Dr. Chelsea C. Pinnix, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vinita Takiar, MD |
|
|
Dr. Gary V. Walker, MD |
|
|
Dr. Jonathan Verma, MD
This Doctor is OpenDoctor Recommended.
|